Detalhe da pesquisa
1.
Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study.
Br J Haematol
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485116
2.
Chronic lymphocytic leukaemia Australasian consensus practice statement.
Intern Med J
; 53(9): 1678-1691, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37743239
3.
Haematological features, transfusion management and outcomes of massive obstetric haemorrhage: findings from the Australian and New Zealand Massive Transfusion Registry.
Br J Haematol
; 190(4): 618-628, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32064584
4.
Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre.
Intern Med J
; 52(7): 1286-1287, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35879233
5.
Fertility in premenopausal women post autologous stem cell transplant with BEAM conditioning.
Eur J Haematol
; 97(4): 348-52, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26773518
6.
Severe intravenous immunoglobulin-induced hemolysis with pigment nephropathy managed with red cell exchange.
J Clin Apher
; 31(5): 464-6, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26297048
7.
Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial.
Clin Cancer Res
; 29(13): 2385-2393, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37074726
8.
Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapy.
EJHaem
; 4(1): 216-220, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819189
9.
Robust SARS-CoV-2 T cell responses with common TCRαß motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells.
Cell Rep Med
; 4(4): 101017, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030296
10.
Toxicity associated with high-dose intravenous methotrexate for hematological malignancies.
Leuk Lymphoma
; 63(10): 2375-2382, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575146
11.
Review of Venetoclax in CLL, AML and Multiple Myeloma.
J Pers Med
; 11(6)2021 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34073976
12.
Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Beyond Ibrutinib.
Hematol Oncol Clin North Am
; 35(4): 761-773, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34174985
13.
Management of Ibrutinib Toxicities: a Practical Guide.
Curr Hematol Malig Rep
; 15(3): 177-186, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32415406
14.
The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia.
Leuk Lymphoma
; 60(7): 1796-1802, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30632843